Search Results - "O’Doherty, Michael J"

False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review by Chalkidou, Anastasia, O'Doherty, Michael J, Marsden, Paul K

“…A number of recent publications have proposed that a family of image-derived indices, called texture features, can predict clinical outcome in patients with…”
Get full text

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group by Barrington, Sally F, Mikhaeel, N George, Kostakoglu, Lale, Meignan, Michel, Hutchings, Martin, Müeller, Stefan P, Schwartz, Lawrence H, Zucca, Emanuele, Fisher, Richard I, Trotman, Judith, Hoekstra, Otto S, Hicks, Rodney J, O'Doherty, Michael J, Hustinx, Roland, Biggi, Alberto, Cheson, Bruce D

“…Recent advances in imaging, use of prognostic indices, and molecular profiling techniques have the potential to improve disease characterization and outcomes…”
Get full text

PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study by Barrington, Sally F., Kirkwood, Amy A., Franceschetto, Antonella, Fulham, Michael J., Roberts, Thomas H., Almquist, Helén, Brun, Eva, Hjorthaug, Karin, Viney, Zaid N., Pike, Lucy C., Federico, Massimo, Luminari, Stefano, Radford, John, Trotman, Judith, Fosså, Alexander, Berkahn, Leanne, Molin, Daniel, D'Amore, Francesco, Sinclair, Donald A., Smith, Paul, O'Doherty, Michael J., Stevens, Lindsey, Johnson, Peter W.

“…International guidelines recommend that positron emission tomography-computed tomography (PET-CT) should replace CT in Hodgkin lymphoma (HL). The aims of this…”
Get full text

Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study by Barrington, Sally F, Phillips, Elizabeth H, Counsell, Nicholas, Hancock, Barry, Pettengell, Ruth, Johnson, Peter, Townsend, William, Culligan, Dominic, Popova, Bilyana, Clifton-Hadley, Laura, McMillan, Andrew, Hoskin, Peter, O'Doherty, Michael J, Illidge, Tim, Radford, John

“…Accurate stratification of patients is an important goal in Hodgkin lymphoma (HL), but the role of pretreatment clinical risk stratification in the context of…”
Get full text

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma by Barrington, Sally F., Qian, Wendi, Somer, Edward J., Franceschetto, Antonella, Bagni, Bruno, Brun, Eva, Almquist, Helén, Loft, Annika, Højgaard, Liselotte, Federico, Massimo, Gallamini, Andrea, Smith, Paul, Johnson, Peter, Radford, John, O’Doherty, Michael J.

“…Purpose To determine if PET reporting criteria for the Response Adapted Treatment in Hodgkin Lymphoma (RATHL) trial could enable satisfactory agreement to be…”
Get full text

[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1 by Warbey, Victoria S., Ferner, Rosalie E., Dunn, Joel T., Calonje, Eduardo, O’Doherty, Michael J.

“…Purpose The detection of malignant peripheral nerve sheath tumours (MPNSTs) in patients with neurofibromatosis 1 (NF1) remains a clinical challenge. The…”
Get full text

Synthesis and biological evaluation of [18F]tetrafluoroborate: a PET imaging agent for thyroid disease and reporter gene imaging of the sodium/iodide symporter by Jauregui-Osoro, Maite, Sunassee, Kavitha, Weeks, Amanda J., Berry, David J., Paul, Rowena L., Cleij, Marcel, Banga, Jasvinder Paul, O’Doherty, Michael J., Marsden, Paul K., Clarke, Susan E. M., Ballinger, James R., Szanda, Istvan, Cheng, Sheue-Yann, Blower, Philip J.

“…Purpose The human sodium/iodide symporter (hNIS) is a well-established target in thyroid disease and reporter gene imaging using gamma emitters 123 I-iodide,…”
Get full text

Role of 18F-FDG PET imaging in paediatric primary dystonia and dystonia arising from neurodegeneration with brain iron accumulation by Szyszko, Teresa A., Dunn, Joel T., O’Doherty, Michael J., Reed, Laurence, Lin, Jean-Pierre

“…PURPOSENo current neuroimaging modality offers mechanistic or prognostic information to guide management in paediatric dystonia. We assessed…”
Get full text

18Fluorodeoxyglucose Positron Emission Tomography in the Prediction of Relapse in Patients With High-Risk, Clinical Stage I Nonseminomatous Germ Cell Tumors: Preliminary Report of MRC Trial TE22—The NCRI Testis Tumour Clinical Study Group by Huddart, Robert A, O'Doherty, Michael J, Padhani, Anwar, Rustin, Gordon J S, Mead, Graham M, Joffe, Johnathan K, Vasey, Paul, Harland, Stephen J, Logue, John, Daugaard, Gedske, Hain, Sharon F, Kirk, Sarah J, MacKewn, Jane E, Stenning, Sally P

“…There are several management options for patients with clinical stage I (CS1) nonseminomatous germ cell tumors (NSGCT); this study examined whether an…”
Get full text

Comparing approaches to correct for respiratory motion in NH3 PET-CT cardiac perfusion imaging by Schleyer, Paul J, O’Doherty, Michael J, Barrington, Sally F, Morton, Geraint, Marsden, Paul K

“…AIMRespiratory motion affects cardiac PET-computed tomography (CT) imaging by reducing attenuation correction (AC) accuracy and by introducing blur. The aim of…”
Get full text

Neurofibroma and schwannoma by Ferner, Rosalie E, O'Doherty, Michael J

“…Neurofibromas and schwannomas are benign peripheral nerve sheath tumours that occur as isolated sporadic lesions, but have their major clinical impact on the…”
Get full text

Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer by Saunders, Catherine A.B, Dussek, Julian E, O’Doherty, Michael J, Maisey, Michael N

“…Background. Surgical resection of lung cancer remains the treatment of choice in appropriately staged disease, but conventional imaging techniques have…”
Get full text

A method for accurate spatial registration of PET images and histopathology slices by Puri, Tanuj, Chalkidou, Anastasia, Henley-Smith, Rhonda, Roy, Arunabha, Barber, Paul R., Guerrero-Urbano, Teresa, Oakley, Richard, Simo, Ricard, Jeannon, Jean-Pierre, McGurk, Mark, Odell, Edward W., O’Doherty, Michael J., Marsden, Paul K.

“…Background Accurate alignment between histopathology slices and positron emission tomography (PET) images is important for radiopharmaceutical validation…”
Get full text

FDG‐PET/CT after two cycles of R‐CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome – final result of a UK National Cancer Research Institute prospective study by Mikhaeel, N. George, Cunningham, David, Counsell, Nicholas, McMillan, Andrew, Radford, John A., Ardeshna, Kirit M., Lawrie, Anthony, Smith, Paul, Clifton‐Hadley, Laura, O'Doherty, Michael J., Barrington, Sally F.

“…Summary The UK National Cancer Research Institute initiated a prospective study (UKCRN‐ID 1760) to assess the prognostic value of early fluorodeoxyglucose…”
Get full text

Observer variation in FDG PET-CT for staging of non-small-cell lung carcinoma by Hofman, Michael S., Smeeton, Nigel C., Rankin, Sheila C., Nunan, Tom, O’Doherty, Michael J.

“…Purpose Error and variation in reporting remains one of the weakest features of clinical imaging despite enormous technological advances in nuclear medicine…”
Get full text

18F--tetrafluoroborate (18F--TFB), a PET probe for imaging sodium-iodide symporter expression: Whole-body biodistribution, safety and radiation dosimetry in thyroid cancer patients by O’ Doherty, Jim, Jauregui-Osoro, Maite, Brothwood, Teresa, Szyszko, Teresa, Marsden, Paul K., O’ Doherty, Michael J., Cook, Gary J. R., Blower, Philip J., Lewington, Val

Get full text

Sentinel lymph node biopsy in differentiated thyroid cancer: Standard of care or experimental tool? by Rubello, Domenico, OʼDoherty, Michael J

Get full text

Use of the CT component of PET-CT to improve PET-MR registration: demonstration in soft-tissue sarcoma by Somer, Edward J, Benatar, Nigel A, O'Doherty, Michael J, Smith, Mike A, Marsden, Paul K

“…We have investigated improvements to PET-MR image registration offered by PET-CT scanning. Ten subjects with suspected soft-tissue sarcomas were scanned with…”
Get more information

Radiopharmaceutical clinical trials – dose is more than sieverts and becquerels by Ballinger, James R., Mather, Stephen J., O’Doherty, Michael J.

“…Clinical trials of radiopharmaceuticals in Europe are regulated by a number of different pieces of legislation in addition to the Clinical Trials Directive…”
Get full text

The new EANM paediatric dosage card--does it conform to ALARA for PET/CT? by Warbey, Victoria S, Schleyer, Paul J, Barrington, Sally F, O'doherty, Michael J

Get full text